COMMUNIQUÉS West-GlobeNewswire

Major shareholder announcement
12/06/2025
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and [...]
New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients
12/06/2025
WAYNE, Pa., June 12, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced findings from a new multinational study reporting efficacy of Arrow™ [...]
BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer
12/06/2025
Acquisition will strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherapy candidates, marking BioNTech’s next key milestone in the execution of its oncology strategy [...]
Catheter Precision (VTAK) Reports Key Progress for the LockeT Product
12/06/2025
FORT MILL, S.C., June 12, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac [...]
I-Mab Regains Compliance with Nasdaq Minimum Bid Price Requirement
12/06/2025
ROCKVILLE, Md., June 12, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (“I-Mab” or the “Company”), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment [...]
Syndax Presents New Revuforj® (revumenib) Data in Relapsed/Refractory mNPM1 and NUP98r Acute Leukemia from AUGMENT-101 Trial at EHA 2025
12/06/2025
– 26% (20/77) CR+CRh rate and 48% (37/77) ORR in efficacy-evaluable pivotal R/R mNPM1 AML population – – Robust responses observed across subgroups, regardless of co-mutations, number of prior lines of therapy, or prior [...]
American Journal of Respiratory and Critical Care Medicine Publishes Landmark Data on AeroPace® System's Breakthrough Results in Ventilator Weaning
12/06/2025
International multi-center trial demonstrates AeroPace strengthens the diaphragm by 50%, weans more patients from ventilation, and reduces ventilator time by 3 days in patients difficult to wean from mechanical [...]
Positive PoNSTEP Study Results Presented at Consortium of Multiple Sclerosis Centers Annual Meeting
12/06/2025
-PoNS Therapeutic Experience Program (PoNSTEP) study demonstrates durable long-term beneficial effects of PoNS Therapy ® on gait deficit improvement in people with Multiple Sclerosis- -Presentation of full PoNSTEP study [...]
Counslr Launches in Texas to Increase Access to Mental Health Support for Staff and Students
12/06/2025
Counslr Provides Unlimited Text-based Mental Health Support and Wellness Resources As Need Grows in Texas School Communities NEW YORK, June 12, 2025 (GLOBE NEWSWIRE) -- Counslr , a leading B2B mental health and wellness [...]
ANI Pharmaceuticals Announces Presentation of New Preclinical Data
12/06/2025
The Use of Purified Cortrophin® Gel in Murine Collagen-Induced Arthritis Mouse Model presented as a poster at the European Alliance of Associations for Rheumatology (EULAR) 2025 Congress PRINCETON, N.J., June 12, 2025 ( [...]
Spring Bio Solution lance NCE Grid pour décoder les dépôts Para IV et les opportunités de premier déposant
12/06/2025
SOMERSET, New Jersey, 12 juin 2025 (GLOBE NEWSWIRE) -- Spring Bio Solution, l’un des leaders mondiaux de l’approvisionnement en comparateurs et en matériel pour essais cliniques , a lancé NCE Grid , une plateforme d’ [...]
Lifecore Biomedical Receives Accelerated Payment of Remaining $10 Million in Proceeds from Prior Equipment Sale
12/06/2025
Fortifies Balance Sheet and Reinforces Disciplined Capital Management Approach CHASKA, Minn., June 12, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR ) (“Lifecore”), a fully integrated contract [...]
Kura Oncology and Kyowa Kirin Report Positive Updated Combination Data for Ziftomenib in Newly Diagnosed AML at 2025 European Hematology Association Congress
12/06/2025
– Encouraging clinical activity with deep responses demonstrated in the KOMET-007 trial with the combination of 600 mg ziftomenib with 7+3 in newly diagnosed patients with NPM1 -m and KMT2A -r AML – – 93% (41/44) and 89 [...]
NewGen Announces Planned US$45 Million Strategic Investment in UAE Real Estate Market
12/06/2025
The Company’s initial investment into the Emirate of Ras Al Khaimah comes ahead of major tourism and infrastructure developments NewGen plans to diversify via additional real estate investments in Abu Dhabi pending [...]
Disc Medicine Presents Positive Clinical Data Updates Across Portfolio at the European Hematology Association (EHA) 2025 Annual Congress
12/06/2025
Positive updates across all programs, including longer term efficacy and safety data from the HELIOS open-label extension trial of bitopertin in erythropoietic protoporphyria (EPP), additional durability data from Phase [...]
Angitia Biopharmaceuticals Announces Topline Results from First in Human Study of AGA2115, A Bispecific Antibody for the Treatment of Osteogenesis Imperfecta
12/06/2025
- AGA2115 also received Orphan Drug Designation from European Medicines Agency WESTLAKE VILLAGE, Calif., June 12, 2025 (GLOBE NEWSWIRE) -- Angitia Biopharmaceuticals, a clinical-stage biotechnology company focused on [...]
Polyrizon Reports Promising Results Demonstrating Successful Internasal Delivery of its Innovative Hydrogel Formulation for CNS Therapeutics
12/06/2025
Ra’anana, Israel, June 12, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a biotechnology company developing intranasal drug delivery systems, today announced encouraging [...]
Aayush Wellness Bridging Ancient Ayurvedic Wisdom with Modern Wellness offering Aayush Herbal Masala – A Natural Alternative
12/06/2025
NEW DELHI, India, June 12, 2025 (GLOBE NEWSWIRE) -- Aayush Wellness Limited , a trailblazer in India's preventive healthcare sector, seamlessly integrates the time-honored principles of Ayurveda with contemporary [...]
Third Harmonic Bio Announces Stockholder Approval of Plan of Liquidation and Dissolution, Updated THB335 Phase 1 Clinical Data, and Initiation of Sale of THB335
12/06/2025
Stockholders overwhelmingly approved liquidation and dissolution of the Company at the June 5, 2025 Annual Meeting Initial distribution currently expected in the range between approximately $5.30 and $5.35 per share of [...]

Pages